Skip to main content
Vivani Medical, Inc. logo

Vivani Medical, Inc. — Investor Relations & Filings

Ticker · VANI ISIN · US81362J2096 US Manufacturing
Filings indexed 803 across all filing types
Latest filing 2026-04-29 Annual Report
Country US United States of America
Listing US VANI

About Vivani Medical, Inc.

https://vivani.com/

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company developing miniaturized, long-term, subdermal drug implants for chronic diseases. The company utilizes its proprietary NanoPortal™ platform technology to provide steady, continuous drug delivery over extended periods, aiming to improve medication adherence and patient outcomes. Its lead product candidate, NPM-139, is a semaglutide implant designed for once or twice-yearly administration for chronic weight management. The pipeline also includes NPM-133, a six-month semaglutide implant for the treatment of type 2 diabetes. The technology's feasibility has been demonstrated in a first-in-human clinical study, paving the way for its pipeline development.

Recent filings

Filing Released Lang Actions
ARS - Vivani Medical, Inc. (0001266806) (Filer)
Annual Report
2026-04-29 English
8-K - Vivani Medical, Inc. (0001266806) (Filer)
Regulatory Filings
2026-03-26 English
10-K - Vivani Medical, Inc. (0001266806) (Filer)
Annual Report FY 2025
2026-03-26 English
4 - VIVANI MEDICAL, INC. (0001266806) (Filer)
Director's Dealing
2026-02-17 English
4 Filing
Director's Dealing
2026-01-28 English
8-K Filing
Regulatory Filings
2026-01-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.